Most Popular Products
Retatrutide China
5.0 USD ($)/Piece
Product Details:
- Application Pharmaceutical
- CAS No 2381089-83-2
- Product Type Peptides
- Shape other
- Smell Other
- HS Code 2937190099
- Shelf Life 24 Months
- Click to View more
X
Retatrutide China Price And Quantity
- 10 Piece
- 5.0 USD ($)/Piece
Retatrutide China Product Specifications
- C221H342N46O68
- Research Grade
- NO
- Other
- Freezer
- 24 Months
- N/A
- Retatrutide
- 99%
- 2381089-83-2
- 1. Core Uses Highly Effective Weight Loss (Obesity Treatment): It is currently the most effective weight loss drug in clinical data. Phase III clinical trials showed that non-diabetic obese individuals who received weekly injections (12 mg dose) of Retatrutide for 80 weeks experienced an average weight loss of 28.3% (nearly 30% of body weight), with nearly half losing more than 30% of their weight an effect comparable to bariatric surgery. Blood Sugar Control (Type 2 Diabetes Treatment): It can significantly lower blood sugar levels in patients with type 2 diabetes, reducing glycated hemoglobin (HbA1c) by an average of approximately 2.0%, helping the vast majority of patients achieve their ideal blood sugar control goals. 2. Other Potential Metabolic Benefits: As clinical research progresses, scientists have discovered that it can also provide the following benefits by improving obesity: Improvement of Non-Alcoholic Fatty Liver Disease:** It has excellent effects in alleviating fatty liver disease. Relief of Obesity Complications:** It can significantly reduce the frequency of sleep apnea (obstructive sleep apnea) and greatly improve knee pain caused by overweight. Improved cardiovascular indicators: Helps lower blood pressure and blood lipids, thereby reducing the risk of heart disease.
- Pharmaceutical
- Retatrutide is an active compound released by Eli Lilly in June 2023. It is a triple (GLP-1/GIP/Gcg) agonist based on the GLP/GI dual receptor agonist Tirzepatide through a hybrid glucagon (GlucagonGcg) related structure, and is a drug for the treatment of obesity and type 2 diabetes. This active compound can activate receptor agonists in our body, which helps control blood sugar and weight loss management.
- White powder
- 2937190099
- Powder
- Soluble in water
- other
- Other
- Peptides
Retatrutide China Trade Information
- Shenzhen
- Telegraphic Transfer (T/T), Western Union
- 10000 Piece Per Week
- 3 Days
- Yes
- If order is confirmed we will reimburse the sample cost
- 10 vials/box
- Asia, Australia, North America, Western Europe
- GMP, ISO
Product Description
Retatrutide is an active compound released by Eli Lilly in June 2023. It is a triple (GLP-1/GIP/Gcg) agonist based on the GLP/GI dual receptor agonist Tirzepatide through a hybrid glucagon (GlucagonGcg) related structure, and is a drug for the treatment of obesity and type 2 diabetes. This active compound can activate receptor agonists in our body, which helps control blood sugar and weight loss management.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Peptide Preparations' category
![]() |
DALIAN HANDOM CHEMICALS CO.,LTD.
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |




